Zenith Renu G55382Recalls & reported problems
Cook Incorporated · Zenith Renu, AAA Ancillary Graft Converter · Class 3 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 10827002553825), received between May 1, 2019 and Oct 10, 2022 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Activation Problem” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Activation Problem1
- Difficult to Remove1
- Material Separation1
- Migration1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
- No Consequences Or Impact To Patient1
- Obstruction/Occlusion1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryOct 10, 2022Difficult to Remove; Material Separation; Migration; Difficult to Remove; Material Separation; Migration
ADDITIONAL INFORMATION WAS RECEIVED ON 18OCT2022 ABOUT THE COOK ZENITH RENU AAA ANCILLARY GRAFT CONVERTER USED DURING A PROCEDURE FOR A PATIENT WITH THE PRE-EXISTING CONDITION OF AN ANGLED NECK. THE PHYSICIAN WAS ABLE TO ORIGINALLY LAND THE DEVICE IN THE PLANNED TARGET ZONE; HOWEVER, THE GRAFT MIGRATED AND THE FABRIC PARTIALLY COVERED THE LEFT RENAL ARTERY. IN RETURN, AN ADDITIONAL PROCEDURE WAS PERFORMED OF STENTING THE LEFT RENAL ARTERY. THE ANGULATION OF THE ANEURYSM NECK RELATIVE TO THE SUPRARENAL AORTA AS WELL AS THE LONG AXIS OF THE AAA WAS ANGLED BUT THE EXACT ANGLE WAS UNKNOWN. THE DELIVERY SYSTEM WAS ROTATED PER IFU. HOWEVER, THE ALTERNATIVE TRIGGER WIRE RELEASE METHOD WAS NOT UTILIZED AS PER LABELING. A 32 CODA BALLOON (UNAVAILABLE LOT NUMBER) WAS USED DURING THE PROCEDURE. NO OTHER ADVERSE EFFECTS WERE REPORTED FOR THIS INCIDENT.
Patient problems: No Clinical Signs, Symptoms or Conditions; Obstruction/Occlusion
MAUDE report 15573338 ↗MalfunctionMay 1, 2019Activation Problem; Activation Problem
NO ADDITIONAL INFORMATION HAS BEEN RECEIVED REGARDING PATIENT AND/OR EVENT DETAILS SINCE THE PREVIOUS MEDWATCH REPORT WAS SENT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8570744 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page